Evaluation of medicinal products for cardiovascular disease prevention

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCHMP/EWP/311890/07
Published25/09/2008
Effective from01/04//2009
KeywordsCardiovascular prevention, risk scoring models, SCORE system, Framingham risk score
DescriptionThis document provides guidance for the clinical evaluation of drugs in the prevention of cardiovascular events.


Document history

First version

Current version

Adopted guideline


Overview of comments


Draft guideline


Concept paper

In operation: 01/04/2009–present


Published: 24/07/2008


Published: 19/07/2007


Published: 23/06/2004


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more